PNC Financial Services Group’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
Other funds holding CGON
RI
DC
TCM
VPM
VCM
PNC Financial Services Group's CGON Position: Q1 2026 in Review
PNC Financial Services Group reduced its CG Oncology (CGON) stake by 11% in Q1 2026, selling an estimated $19.4K and leaving 2,728 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #2380.
PNC Financial Services Group first reported a position in CGON in Q2 2024 and has held it in 8 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.
- PNC Financial Services Group held 2,728 shares of CG Oncology worth $185K as of Q1 2026.
- PNC Financial Services Group sold 342 CG Oncology shares in Q1 2026, an estimated $19.4K.
- CG Oncology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #2380 holding.
- PNC Financial Services Group first reported a position in CG Oncology in Q2 2024 and has held it in 8 quarters since.
- 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.
Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.